Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498.
Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–21.
Patel NJ, Deshmukh A, Pant S, Singh V, Patel N, Arora S, et al. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation. 2014;129(23):2371–9.
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Circulation. 2014;130(23):e199-267.
PubMed PubMed Central Google Scholar
Son YJ, Baek KH, Lee SJ, Seo EJ. Health-related quality of life and associated factors in patients with atrial fibrillation: an integrative literature review. Int J Environ Res Public Health. 2019;16(17):E3042.
Thrall G, Lane D, Carroll D, Lip GYH. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119(5):448.e1-448.e19.
Parameswaran R, Al-Kaisey AM, Kalman JM. Catheter ablation for atrial fibrillation: current indications and evolving technologies. Nat Rev Cardiol. 2021;18(3):210–25.
Cella D, Hahn E, Jensen S, Butt Z, Nowinski C, Rothrock N, et al. Patient-reported outcomes in performance measurement. Triangle Park: RTI Press; 2015.
Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. Oxford: Oxford University Press; 2014.
Chambers D, Booth A, Baxter SK, Johnson M, Dickinson KC, Goyder EC. Literature mapping exercise [Internet]. Evidence for models of diagnostic service provision in the community: literature mapping exercise and focused rapid reviews. NIHR Journals Library; 2016 [cited 2021 Aug 24]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK402230/.
Reynolds MR, Ellis E, Zimetbaum P. Quality of life in atrial fibrillation: measurement tools and impact of interventions. J Cardiovasc Electrophysiol. 2008;19(7):762–8.
Aliot E, Botto GL, Crijns HJ, Kirchhof P. Quality of life in patients with atrial fibrillation: how to assess it and how to improve it. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2014;16(6):787–96.
Kotecha D, Ahmed A, Calvert M, Lencioni M, Terwee CB, Lane DA. Patient-reported outcomes for quality of life assessment in atrial fibrillation: a systematic review of measurement properties. PLoS ONE. 2016;11(11):e0165790.
Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120(9):1501–17.
Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, et al. Atrial fibrillation begets heart failure and vice versa. Circulation. 2016;133(5):484–92.
Terwee CB, Jansma EP, Riphagen II, de Vet HCW. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res. 2009;18(8):1115–23.
Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN Risk of Bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2018;27(5):1171–9.
Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2018;27(5):1147–57.
Tsounis D, Ioannidis A, Bouras G, Raikou M, Giannopoulos G, Deftereos S, et al. Assessment of health-related quality of life in a greek symptomatic population with atrial fibrillation: correlation with functional status and echocardiographic indices. Hell J Cardiol HJC Hell Kardiologike Epitheorese. 2014;55(6):475–85.
Berkowitsch A, Neumann T, Kurzidim K, Reiner C, Kuniss M, Siemon G, et al. Comparison of generic health survey SF-36 and arrhythmia related symptom severity check list in relation to post-therapy AF recurrence. Europace. 2003;5(4):351–5.
Spertus J, Dorian P, Bubien R, Lewis S, Godejohn D, Reynolds MR, et al. Development and validation of the atrial fibrillation effect on QualiTy-of-Life (AFEQT) questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(1):15–25.
Dorian P, Burk C, Mullin CM, Bubien R, Godejohn D, Reynolds MR, et al. Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful? Am Heart J. 2013;166(2):381-387.e8.
Tailachidis P, Tsimtsiou Z, Galanis P, Theodorou M, Kouvelas D, Athanasakis K. The atrial fibrillation effect on quality-of-life (AFEQT) questionnaire: cultural adaptation and validation of the Greek version. Hippokratia. 2016;20(4):264–7.
CAS PubMed PubMed Central Google Scholar
Holmes DN, Piccini JP, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, et al. Defining clinically important difference in the atrial fibrillation effect on quality-of-life score. Circ Cardiovasc Qual Outcomes. 2019;12(5):e005358–e005358.
Gunes F, Boyraz S. Effect of atrial fibrillation on quality of life (AFEQT) questionnaire: a Turkish validity and reliability study. Turk Kardiyol Dernegi Arsivi Turk Kardiyol Derneginin Yayin Organidir. 2021;49(3):223–32.
Li PWC, Yu DSF, Yan BP. Psychometric validation of the Chinese version of atrial fibrillation effect on quality-of-life questionnaire among Chinese patients. Benjamin B Chugh, Ferketich, Guo, Hu, Kline, Koo, Kotecha, Landis, Lee, Rienstra, Rumsfeld, Schnabel, Spertus, Streiner, Sychov, Tabachnick, Tailachidis, Thrall, Wong, editor. J Cardiovasc Nurs. 2021;36(2):136–42.
Dorian P, Paquette M, Newman D, Roy D, Green M, Connolly SJ, et al. Quality of life improves with treatment in the Canadian trial of atrial fibrillation. Am Heart J. 2002;143(6):984–90.
Kahya Eren N, Yakar Tuluce S, Kilicaslan B, Nazli C, Ergene O. The validity and reliability of the Turkish version of the University of Toronto atrial fibrillation severity scale. Turk J Med Sci. 2014;44(6):996–1001.
Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;94(7):1585–91.
Carnlöf C, Malinowsky C, Insulander P, Gadler F, Jensen-Urstad M, Iwarzon M. The symptom checklist: frequency and severity scale—translation and psychometric properties of the Swedish version. Nord J Nurs Res. 2020;40(2):97–104.
Moreira RSL, Bassolli L, Coutinho E, Ferrer P, Braganca EO, Carvalho ACC, et al. Reproducibility and reliability of the quality of life questionnaire in patients with atrial fibrillation. Arq Bras Cardiol. 2016;106(3):171–81.
PubMed PubMed Central Google Scholar
Walfridsson U, Stromberg A, Kristofer A. Development and validation of an arrhythmia-specific scale in tachycardia and arrhythmia with focus on health-related quality of life. J Cardiovasc Nurs. 2015;30(2):98–108.
Lomper K, Sławuta A, Dudek K, Mazur G, Walfridsson U, Jankowska-Polańska B. Psychometric evaluation of the Polish version of the arrhythmia-specific questionnaire in tachycardia and arrhythmia: a new tool for symptom and health-related quality of life assessment. Pol Heart J Kardiologia Pol. 2019;77(5):541–52.
Cannavan PMS, Cannavan FPS, Walfridsson U, Lopes MHBM. Translation and validation of the arrhythmia-specific questionnaire in tachycardia and arrhythmia (ASTA) to the Brazilian context: an instrument focusing on arrhythmia symptoms. Cardiol Res Pract. 2020;10:1–7.
Middel B, Bouma J, de Jongste M, van Sonderen E, Niemeijer MG, Crijns H, et al. Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHF-Q). Bulpitt C Cohen, Cohen, Cohen Solal, Colucci, Crocker, Cronbach, Guyatt, Jenkinson, Jenkinson, Kiers, Kirshner, Kubo, Lipsey, McHorney, Metra, Middel, Nunnally, Patrick, Rector, Rector, Rector, Smets, Smets, Smets, Spinhoven, Ten Berge, Teresi, Van der Zee, Van der Zee, Van der Zee, Varni, Vulink, Zigmond, editor. Clin Rehabil. 2001;15(5):489–500.
Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124(4):1017–25.
Supino PG, Borer JS, Franciosa JA, Preibisz JJ, Hochreiter C, Isom OW, et al. Acceptability and psychometric properties of the minnesota living with heart failure questionnaire among patients undergoing heart valve surgery: validation and comparison With SF-36. J Card Fail. 2009;15(3):267–77.
Hak T, Willems D, van der Wal G, Visser F. A qualitative validation of the Minnesota living with heart failure questionnaire. Qual Life Res. 2004;13(2):417–26.
Coyne K, Margolis MK, Grandy S, Zimetbaum P. The state of patient-reported outcomes in atrial fibrillation. Pharmacoeconomics. 2005;23(7):687–708.
Minnesota living with heart failure questionnaire (MLHF) [Internet]. Mapi Research Trust. [cited 2021 Aug 3]. Available from: https://eprovide.mapi-trust.org/instruments/minnesota-living-with-heart-failure-questionnaire.
SF-36 Health Survey (SF-36®/SF-36v2®) [Internet]. Mapi Research Trust. [cited 2021 Aug 24]. Available from: https://eprovide.mapi-trust.org/instruments/sf-36-health-survey.
AFEQT: Atrial fibrillation effect on quality-of-life [Internet]. [cited 2021 Aug 24]. Available from: https://eprovide.mapi-trust.org/instruments/atrial-fibrillation-effect-on-quality-of-life.
EuroQoL 5-Dimension 3-Level (EQ-5D-3L). Mapi Research Trust.
Terwee CB, Roorda LD, Dekker J, Bierma-Zeinstra SM, Peat G, Jordan KP, et al. Mind the MIC: large variation among populations and methods. J Clin Epidemiol. 2010;63(5):524–34.
留言 (0)